Research progress on CD8  + T cell immune regulation in allogenic transplantation

Transpl Immunol. 2023 Oct 21:101945. doi: 10.1016/j.trim.2023.101945. Online ahead of print.ABSTRACTWith advances in tissue typing, organ preservation techniques, and clinical surgery, organ transplantation has gained popularity as a treatment option for various end-stage diseases. Allogeneic transplantation has been widely adopted and extensively researched in clinical practice. Despite significant breakthroughs and progress in immunosuppression, this procedure is still associated with several adverse reactions and complications. Therefore, there is a continuing need to explore new immunological approaches to provide fresh insights and guidance for clinical transplantation. CD8 + T cells, traditionally known for their cytotoxic function and their ability to recognize transplanted organs as "non-self" entities, display cytotoxicity. However, recent studies have unveiled that CD8 + T cells have various subtypes and functions that extend beyond conventional cytotoxicity. These CD8 + T cell subtypes include Effector CD8 + T cells, Memory CD8 + T cells, and CD8Treg cells. This review examines the immune regulatory mechanisms of CD8 + T cells in allogeneic transplantation and discusses the potential applications of CD8 + T cells in treating tumors in transplant recipients who are receiving immunosuppressive therapy. These findings offer theoretical guidance for reducing post-transplant rejection reactions and improving adverse prognoses, offering new hope for improved clinical sur...
Source: Transplant Immunology - Category: Transplant Surgery Authors: Source Type: research